Literature DB >> 15891322

Heliox improves hemodynamics in mechanically ventilated patients with chronic obstructive pulmonary disease with systolic pressure variations.

David Lin Lee1, Huan Lee, Hsueh-Wen Chang, Alice Y W Chang, Shoa-Lin Lin, Yuh-Chin T Huang.   

Abstract

OBJECTIVE: To test the hypothesis that, compared with air-oxygen, heliox would improve cardiac performance in mechanically ventilated patients with severe chronic obstructive pulmonary disease and systolic pressure variations >15 mm Hg and to determine clinical variables associated with favorable hemodynamic responses to heliox.
DESIGN: A prospective interventional study.
SETTING: Medical and respiratory intensive care units at a university-affiliated tertiary medical center. PATIENTS: Twenty-five consecutive mechanically ventilated patients with severe chronic obstructive pulmonary disease and acute respiratory failure who had systolic pressure variations >15 mm Hg.
INTERVENTIONS: Respiratory and hemodynamic measurements were taken at the following time with the same ventilator setting: a) baseline; b) after 30 mins with heliox; and c) 30 mins after return to air-oxygen.
MEASUREMENTS AND MAIN RESULTS: Heliox ventilation decreased intrinsic positive end-expiratory pressure (air-oxygen vs. heliox [mean +/- sd] 13 +/- 4 cm H2O vs. 5 +/- 2 cm H2O, p < .05), trapped lung volume (air-oxygen vs. heliox 362 +/- 67 mL vs. 174 +/- 86 mL, p < .05), and respiratory changes in systolic pressure variations (DeltaPP) (air-oxygen vs. heliox 29 +/- 5% vs. 13 +/- 7%, p < .05). In the ten patients with pulmonary arterial catheters, heliox decreased mean pulmonary arterial pressure, right atrial pressure, and pulmonary arterial occlusion pressure and increased cardiac index. Preheliox DeltaPP correlated with the magnitude of reduction in intrinsic positive end-expiratory pressure during heliox ventilation. Age, preheliox Paco2, and ratio of forced expiratory volume at first second to forced vital capacity correlated inversely, whereas preheliox DeltaPP correlated positively with increases in cardiac index.
CONCLUSIONS: Heliox may be a useful adjunct therapy in patients with severe chronic obstructive pulmonary disease during acute respiratory failure who have persistent intrinsic positive end-expiratory pressure-induced hemodynamic changes despite ventilator management.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15891322     DOI: 10.1097/01.ccm.0000163403.42842.fe

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  A proof-of-concept trial of HELIOX with different fractions of helium in a human study modeling upper airway obstruction.

Authors:  Hubert Truebel; Sandra Wuester; Philip Boehme; Hinnerk Doll; Sven Schmiedl; Jacek Szymanski; Thorsten Langer; Thomas Ostermann; Dirk Cysarz; Petra Thuermann
Journal:  Eur J Appl Physiol       Date:  2019-03-08       Impact factor: 3.078

2.  Effect of heliox on heart rate kinetics and dynamic hyperinflation during high-intensity exercise in COPD.

Authors:  Pierantonio Laveneziana; Gabriele Valli; Paolo Onorati; Patrizia Paoletti; Alessandro Maria Ferrazza; Paolo Palange
Journal:  Eur J Appl Physiol       Date:  2010-09-18       Impact factor: 3.078

Review 3.  [Bronchial obstruction in intensive care].

Authors:  T Wagner
Journal:  Internist (Berl)       Date:  2006-04       Impact factor: 0.743

Review 4.  Clinical review: use of helium-oxygen in critically ill patients.

Authors:  Marc Gainnier; Jean-Marie Forel
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

5.  The use of heliox in critical care.

Authors:  Seyed Mohammadreza Hashemian; Farahnaz Fallahian
Journal:  Int J Crit Illn Inj Sci       Date:  2014-04

6.  Pulse pressure variation: beyond the fluid management of patients with shock.

Authors:  Frédéric Michard; Marcel R Lopes; Jose-Otavio C Auler
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.